dr_seong
TL3 Physician · Busan, KR
Family medicine. Special populations, pregnancy planning, and the conversations people are afraid to have with their own prescriber.
Joined 8 December 2024 · last posted 4d · groups: clinicians
136 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #31 · Clinical › Bloodwork · 24 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why the Start Here categories exist, and what they are not for Replied, post #23 · Start Here › Welcome · 22 Jul 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #134 · Practice › Reconstitution · 21 Jul 2026 · 32 likes Picking up post #131: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #70 · Practice › Interactions · 21 Jul 2026 · 4 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Pooling trials with different estimands Replied, post #115 · Evidence › Meta-analyses · 21 Jul 2026 · 2 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #33 · Practice › Reconstitution · 18 Jul 2026 · 17 likes I read post #31 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #83 · Analytics › Impurities & related substances · 16 Jul 2026 · 7 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #46 · Pharmacology › Receptor biology · 16 Jul 2026 · 15 likes post #45 is right about the mechanism and I think understates the practical bit. Long-term receptor changes: very little is known about what happens to receptor…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #69 · Access › Insurance & coverage · 12 Jul 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Substitution between formats during a shortage — what changed since Replied, post #9 · Access › Shortages · 12 Jul 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #49 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 3 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Retatrutide mass and identity: what a report should show Replied, post #12 · Compounds › Retatrutide · 7 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #15 · Practice › Side effects · 6 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A calculator that gives a right answer to the wrong question Replied, post #30 · Data & Tools › Calculators · 26 Jun 2026 · 1 like Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Does a peptide degrade silently, with no visual change? Replied, post #54 · Practice › Storage & stability · 23 Jun 2026 · 25 likes I read post #52 twice before replying, because I had assumed the opposite. Temperature excursions: if a vial sat at room temperature for a time, the question is whether…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #46 · Compounds › Tirzepatide · 19 Jun 2026 · 0 likes Picking up post #43: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Official shortage notices and what they authorise Replied, post #70 · Access › Shortages · 26 May 2026 · 3 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #18 · Lounge › Introductions · 18 May 2026 · 5 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
The anatomy of a question that gets answered within an hour Replied, post #40 · Start Here › How to Ask · 9 May 2026 · 1 like Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #66 · Research Methods › N-of-1 designs · 8 May 2026 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #37 · Practice › Reconstitution · 4 May 2026 · 11 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #103 · Compounds › Tirzepatide · 29 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #42 · Compounds › Repair & healing peptides · 23 Apr 2026 · 5 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
About the Insurance & coverage category Replied, post #3 · Access › Insurance & coverage · 20 Apr 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #13 · Analytics › Impurities & related substances · 19 Apr 2026 · 12 likes Coming back to post #11, because the follow-up matters more than the original answer. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #31 · Meta › Announcements · 15 Apr 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: State-level differences that actually matter Replied, post #72 · Regional › North America · 7 Apr 2026 · 9 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
Constipation management, with a dietitian's contribution Replied, post #48 · Practice › Side effects · 3 Apr 2026 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Designing a personal experiment that could change your mind — one year on Replied, post #28 · Research Methods › N-of-1 designs · 2 Apr 2026 · 1 like post #27 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #90 · Clinical › Special populations · 29 Mar 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #61 · Compounds › Tirzepatide · 28 Mar 2026 · 0 likes On post #57 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #3 · Evidence › Journal club · 28 Mar 2026 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #54 · Compounds › Tirzepatide · 22 Mar 2026 · 14 likes I read post #52 twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Second pass at: What pooling buys you and what it destroys Replied, post #29 · Evidence › Meta-analyses · 20 Mar 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a certificate commits its issuer to — one year on Replied, post #31 · Analytics › COA interpretation · 13 Mar 2026 · 4 likes On post #27 — agreed on the reasoning, with one qualification. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…
-
About the Doc review category Replied, post #3 · Documentation › Doc review · 13 Mar 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Request: export my own posts — one year on Replied, post #58 · Meta › Feature requests · 12 Mar 2026 · 27 likes Worth separating two things that post #54 runs together. Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #38 · Practice › Reconstitution · 11 Mar 2026 · 12 likes Worth separating two things that post #34 runs together. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #12 · Sourcing › Logistics · 6 Mar 2026 · 25 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #9 · Clinical › Bloodwork · 5 Mar 2026 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #92 · Clinical › Bloodwork · 5 Mar 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #36 · Analytics › Impurities & related substances · 24 Feb 2026 · 2 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Primary endpoint hierarchies and why order matters Replied, post #2 · Evidence › Trials · 22 Feb 2026 · 15 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #10 · Outcomes › Progress reports · 18 Feb 2026 · 24 likes Picking up post #7: that is the part I would want checked first. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #56 · Practice › Dosing & titration · 18 Feb 2026 · 24 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Preprint servers and what screening they do Replied, post #58 · Evidence › Preprints · 16 Feb 2026 · 4 likes On post #54 — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #16 · Outcomes › Body composition · 14 Feb 2026 · 2 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #52 · Analytics › Mass spectrometry · 13 Feb 2026 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #63 · Documentation › Wiki requests · 30 Jan 2026 · 5 likes I read post #61 twice before replying, because I had assumed the opposite. Scope creep: if you think a page is attempting too much and should be split into multiple…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #18 · Access › International · 28 Jan 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #60 · Clinical › Special populations · 24 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #87 · Practice › Side effects · 21 Jan 2026 · 7 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #16 · Outcomes › Body composition · 20 Jan 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: What to keep a record of at the point of payment Replied, post #3 · Sourcing › Payments · 16 Jan 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Realistic expectations for strength while losing weight quickly Replied, post #52 · Nutrition & Training › Resistance training · 10 Jan 2026 · 0 likes This follows post #49 rather than contradicting it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to…
-
A partial dose because the pen emptied mid-injection Replied, post #69 · Practice › Administration · 9 Jan 2026 · 20 likes On post #65 — agreed on the reasoning, with one qualification. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #99 · Analytics › Home & field testing · 7 Jan 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #42 · Practice › Side effects · 6 Jan 2026 · 0 likes Picking up post #39: that is the part I would want checked first. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to…
-
Heterogeneity as information rather than as a nuisance Replied, post #49 · Evidence › Meta-analyses · 4 Jan 2026 · 3 likes post #48 is right about the mechanism and I think understates the practical bit. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #36 · Pharmacology › Receptor biology · 31 Dec 2025 · 15 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Aggregates and why a purity assay may miss them entirely Replied, post #14 · Analytics › Impurities & related substances · 18 Dec 2025 · 3 likes I read post #12 twice before replying, because I had assumed the opposite. Off-target structures: if the sequence synthesis goes wrong, a completely different amino…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #121 · Practice › Reconstitution · 16 Dec 2025 · 6 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #23 · Compounds › Tirzepatide · 3 Dec 2025 · 27 likes Picking up post #20: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
MHRA statements, read directly Replied, post #41 · Regional › UK & Ireland · 1 Dec 2025 · 25 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #5 · Practice › Reconstitution · 22 Nov 2025 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #41 · Analytics › Impurities & related substances · 22 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #124 · Start Here › How to Ask · 21 Nov 2025 · 7 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Prescription requirements and telehealth models Replied, post #22 · Sourcing › Regulatory · 20 Nov 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
[2026 update] What steady state means for the decision to escalate Replied, post #126 · Practice › Dosing & titration · 18 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Personal import allowances, compared — a second dataset Replied, post #22 · Access › International · 14 Nov 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Compounding in different countries: some countries allow pharmacy compounding under defined…
-
Publishing an inconvenient result: a case study — the long version Replied, post #37 · Sourcing › Independent verification · 14 Nov 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #6 · Compounds › Tirzepatide · 6 Nov 2025 · 27 likes post #5 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Sleep quality changes during weight loss — what changed since Replied, post #51 · Wellbeing › Sleep · 4 Nov 2025 · 2 likes post #50 answers the question as asked. The question underneath it is different. Gastrointestinal effects overnight: nausea or reflux or constipation at night can…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #85 · Documentation › Doc review · 1 Nov 2025 · 15 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
New subcategory: rationale and scope Replied, post #84 · Meta › Announcements · 22 Oct 2025 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #96 · Practice › Storage & stability · 21 Oct 2025 · 26 likes On post #92 — agreed on the reasoning, with one qualification. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
-
Injection discomfort: needle gauge, volume, temperature, technique — one year on Replied, post #3 · Practice › Administration · 20 Oct 2025 · 24 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #72 · Compounds › Semaglutide · 9 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #3 · Evidence › Preprints · 25 Sep 2025 · 1 like Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Why the timeline is on the right and not the left Replied, post #73 · Meta › Site feedback · 24 Sep 2025 · 15 likes Coming back to post #71, because the follow-up matters more than the original answer. Accessibility: screen readers, keyboard navigation, contrast, font size — if…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #78 · Practice › Side effects · 20 Sep 2025 · 0 likes Coming back to post #76, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #49 · Analytics › HPLC & UHPLC · 16 Sep 2025 · 8 likes Picking up post #46: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #30 · Compounds › Tirzepatide · 23 Aug 2025 · 8 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Liver enzymes drifting down and what that usually means Replied, post #6 · Clinical › Bloodwork · 22 Aug 2025 · 1 like This follows post #3 rather than contradicting it. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #103 · Compounds › Repair & healing peptides · 15 Aug 2025 · 8 likes Picking up post #100: that is the part I would want checked first. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral…
-
A request that was declined, and the reasoning — a second dataset Replied, post #93 · Documentation › Wiki requests · 15 Aug 2025 · 6 likes Picking up post #90: that is the part I would want checked first. Translation suggestions: if a maintained page should exist in another language, suggesting it here…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #2 · Analytics › Impurities & related substances · 9 Aug 2025 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Canadian access and provincial variation — one year on Replied, post #20 · Regional › North America · 23 Jul 2025 · 0 likes Worth separating two things that post #16 runs together. Regional variation in North America: access differs substantially by US state and Canadian province. Postcode…
-
Preparing for an appointment: one page, three questions Replied, post #28 · Clinical › Prescriber conversations · 21 Jul 2025 · 2 likes On post #24 — agreed on the reasoning, with one qualification. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours…
-
Sodium, potassium and magnesium when intake drops Replied, post #67 · Nutrition & Training › Hydration & electrolytes · 20 Jul 2025 · 18 likes This follows post #64 rather than contradicting it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #3 · Analytics › Method validation · 17 Jul 2025 · 25 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #63 · Clinical › Comorbidities · 2 Jul 2025 · 1 like Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #30 · Compounds › Semaglutide · 16 Jun 2025 · 11 likes post #29 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Counter-ion content and its effect on measured mass Replied, post #63 · Analytics › Mass spectrometry · 13 Jun 2025 · 19 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Which panel is worth repeating and which is worth ignoring Replied, post #36 · Clinical › Bloodwork · 11 Jun 2025 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Sequence verification for an obscure compound: how it is done Replied, post #55 · Compounds › Other compounds · 6 Jun 2025 · 5 likes post #54 answers the question as asked. The question underneath it is different. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #112 · Data & Tools › Calculators · 4 Jun 2025 · 6 likes Coming back to post #110, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #30 · Sourcing › Vendor reports · 26 May 2025 · 1 like post #29 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #5 · Compounds › Semaglutide · 20 May 2025 · 16 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #39 · Practice › Storage & stability · 12 May 2025 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #3 · Devices › Pens & autoinjectors · 8 May 2025 · 9 likes post #2 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #92 · Sourcing › Red flags · 8 May 2025 · 4 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Reading an MS report that only gives you a single number Replied, post #73 · Analytics › Mass spectrometry · 8 May 2025 · 0 likes Worth separating two things that post #69 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
When "no data" is the complete and final answer Replied, post #166 · Compounds › Other compounds · 2 May 2025 · 0 likes post #165 answers the question as asked. The question underneath it is different. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #11 · Evidence › Journal club · 17 Apr 2025 · 0 likes On post #7 — agreed on the reasoning, with one qualification. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #11 · Evidence › Trials · 14 Apr 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #96 · Evidence › Journal club · 13 Apr 2025 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #2 · Compounds › Retatrutide · 8 Apr 2025 · 9 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Retatrutide dose escalation in the published trials Replied, post #78 · Compounds › Retatrutide · 2 Apr 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coverage for the indication versus for the drug Replied, post #12 · Access › Insurance & coverage · 28 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why the timeline is on the right and not the left Replied, post #3 · Meta › Site feedback · 25 Mar 2025 · 29 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #62 · Practice › Reconstitution · 24 Mar 2025 · 10 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Revisiting: German, French and Dutch differences, compared Replied, post #5 · Regional › European Union · 22 Mar 2025 · 0 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #130 · Pharmacology › Receptor biology · 19 Mar 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #97 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #72 · Sourcing › Vendor reports · 17 Mar 2025 · 6 likes Worth separating two things that post #68 runs together. Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way.…
-
Validating a method you did not develop — does this still hold? Replied, post #118 · Analytics › Method validation · 15 Mar 2025 · 14 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Reading order for a first week here, and what to skip until later Replied, post #36 · Start Here › Welcome · 14 Mar 2025 · 19 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Storing a pen in use versus a pen unopened Replied, post #2 · Devices › Pens & autoinjectors · 8 Mar 2025 · 24 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Scheduled maintenance and what will be unavailable Replied, post #53 · Meta › Announcements · 24 Feb 2025 · 3 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #5 · Practice › Administration · 15 Feb 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #15 · Analytics › Mass spectrometry · 12 Feb 2025 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #36 · Access › International · 10 Feb 2025 · 32 likes post #35 answers the question as asked. The question underneath it is different. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
Prior authorisation: what the criteria usually require Replied, post #3 · Access › Insurance & coverage · 4 Feb 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Started this topic · Compounds › Tirzepatide · 2 Jan 2025 · 0 likes The question in the title: What the GIP component of tirzepatide is thought to contribute, and how confident we can be I will give what I have already checked below so…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #17 · Documentation › Doc review · 22 Dec 2024 · 26 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #57 · Compounds › Semaglutide · 22 Dec 2024 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Reading a supplementary appendix and finding the interesting part Replied, post #30 · Evidence › Trials · 24 Nov 2024 · 18 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #38 · Sourcing › Independent verification · 19 Nov 2024 · 6 likes On post #34 — agreed on the reasoning, with one qualification. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells…
-
What a seizure notice actually says Replied, post #6 · Sourcing › Logistics · 3 Nov 2024 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Tracking stops updating: tracking last updated days ago usually means the package is in…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #10 · Compounds › Tirzepatide · 26 Oct 2024 · 7 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
The topic list is dense — is that deliberate? Replied, post #43 · Meta › Site feedback · 25 Oct 2024 · 5 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #69 · Practice › Dosing & titration · 23 Sep 2024 · 4 likes On post #65 — agreed on the reasoning, with one qualification. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #14 · Compounds › Oral incretins · 23 Aug 2024 · 13 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #7 · Analytics › Method validation · 20 Aug 2024 · 12 likes I read post #5 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #42 · Practice › Dosing & titration · 8 Jul 2024 · 28 likes I read post #40 twice before replying, because I had assumed the opposite. Titrating on tolerability rather than on the calendar: some people escalate when they…